Sign up for Table of Contents Alerts.
Email this page
Print this page
Commentary
Could the Combination of Celecoxib and 4HPR be an Effective Lung Cancer Treatment?
Durga P. Cherukuri and Mark A. Nelson
volume 4 | issue 8
august 2005Pages: 899-900
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.
Commentary to:
Enhanced growth inhibition and apoptosis induction in NSCLC cell lines by combination of celecoxib and 4HPR at clinically relevant concentrations
Shi-Yong Sun, Claudia P Schroeder, Ping Yue, Dafna Lotan, Waun K Hong, Reuben Lotan
Cancer Biol Ther 4(4); 2005:407-413
We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:
Download PDFIf the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.